Jefferies Boosts Numbers on Questcor (QCOR) After Including Acthar DM/PM Sales in Model

June 15, 2012 7:27 AM EDT Send to a Friend
Jefferies lifted estimates and its price target on Buy-rated Questcor Pharmaceuticals (NASDAQ: QCOR) to $56.00 (from $52.00) after a call ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login